271 related articles for article (PubMed ID: 35706003)
1. The role of insulin-like growth factor 2 mRNA binding proteins in female reproductive pathophysiology.
Xu X; Shen HR; Zhang JR; Li XL
Reprod Biol Endocrinol; 2022 Jun; 20(1):89. PubMed ID: 35706003
[TBL] [Abstract][Full Text] [Related]
2. IMPs: an RNA-binding protein family that provides a link between stem cell maintenance in normal development and cancer.
Degrauwe N; Suvà ML; Janiszewska M; Riggi N; Stamenkovic I
Genes Dev; 2016 Nov; 30(22):2459-2474. PubMed ID: 27940961
[TBL] [Abstract][Full Text] [Related]
3. Association of maternal polycystic ovary syndrome and diabetes with preterm birth and offspring birth size: a population-based cohort study.
Chen X; Gissler M; Lavebratt C
Hum Reprod; 2022 May; 37(6):1311-1323. PubMed ID: 35348682
[TBL] [Abstract][Full Text] [Related]
4. Adiponectin and the control of female reproductive functions.
Palin MF; Bordignon VV; Murphy BD
Vitam Horm; 2012; 90():239-87. PubMed ID: 23017719
[TBL] [Abstract][Full Text] [Related]
5. Expression of the genes encoding the insulin-like growth factors (IGF-I and II), the IGF and insulin receptors, and IGF-binding proteins-1-6 and the localization of their gene products in normal and polycystic ovary syndrome ovaries.
el-Roeiy A; Chen X; Roberts VJ; Shimasakai S; Ling N; LeRoith D; Roberts CT; Yen SS
J Clin Endocrinol Metab; 1994 Jun; 78(6):1488-96. PubMed ID: 7515389
[TBL] [Abstract][Full Text] [Related]
6. A family of IGF-II mRNA binding proteins (IMP) involved in RNA trafficking.
Nielsen FC; Nielsen J; Christiansen J
Scand J Clin Lab Invest Suppl; 2001; 234():93-9. PubMed ID: 11713986
[TBL] [Abstract][Full Text] [Related]
7. Impact of insulin resistance on pregnancy complications and outcome in women with polycystic ovary syndrome.
Bjercke S; Dale PO; Tanbo T; Storeng R; Ertzeid G; Abyholm T
Gynecol Obstet Invest; 2002; 54(2):94-8. PubMed ID: 12566751
[TBL] [Abstract][Full Text] [Related]
8. Preconception predictors of gestational diabetes: a multicentre prospective cohort study on the predominant complication of pregnancy in polycystic ovary syndrome.
de Wilde MA; Veltman-Verhulst SM; Goverde AJ; Lambalk CB; Laven JS; Franx A; Koster MP; Eijkemans MJ; Fauser BC
Hum Reprod; 2014 Jun; 29(6):1327-36. PubMed ID: 24777850
[TBL] [Abstract][Full Text] [Related]
9. Gestational diabetes mellitus risk factors in women with polycystic ovary syndrome (PCOS).
Ashrafi M; Sheikhan F; Arabipoor A; Hosseini R; Nourbakhsh F; Zolfaghari Z
Eur J Obstet Gynecol Reprod Biol; 2014 Oct; 181():195-9. PubMed ID: 25150960
[TBL] [Abstract][Full Text] [Related]
10. Insulin action in women with polycystic ovary syndrome and its relation to gestational diabetes.
de Wilde MA; Goverde AJ; Veltman-Verhulst SM; Eijkemans MJ; Franx A; Fauser BC; Koster MP
Hum Reprod; 2015 Jun; 30(6):1447-53. PubMed ID: 25840428
[TBL] [Abstract][Full Text] [Related]
11. A family of insulin-like growth factor II mRNA-binding proteins represses translation in late development.
Nielsen J; Christiansen J; Lykke-Andersen J; Johnsen AH; Wewer UM; Nielsen FC
Mol Cell Biol; 1999 Feb; 19(2):1262-70. PubMed ID: 9891060
[TBL] [Abstract][Full Text] [Related]
12. Obstetric complications after frozen versus fresh embryo transfer in women with polycystic ovary syndrome: results from a randomized trial.
Zhang B; Wei D; Legro RS; Shi Y; Li J; Zhang L; Hong Y; Sun G; Zhang T; Li W; Chen ZJ
Fertil Steril; 2018 Feb; 109(2):324-329. PubMed ID: 29338857
[TBL] [Abstract][Full Text] [Related]
13. Impact of comorbid polycystic ovarian syndrome and gestational diabetes mellitus on pregnancy outcomes: a retrospective cohort study.
Manoharan V; Wong VW
BMC Pregnancy Childbirth; 2020 Aug; 20(1):484. PubMed ID: 32831037
[TBL] [Abstract][Full Text] [Related]
14. The biological function of IGF2BPs and their role in tumorigenesis.
Du QY; Zhu ZM; Pei DS
Invest New Drugs; 2021 Dec; 39(6):1682-1693. PubMed ID: 34251559
[TBL] [Abstract][Full Text] [Related]
15. Diabetes and the female reproductive system.
Nandi A; Poretsky L
Endocrinol Metab Clin North Am; 2013 Dec; 42(4):915-46. PubMed ID: 24286956
[TBL] [Abstract][Full Text] [Related]
16. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME - PART 2.
Goodman NF; Cobin RH; Futterweit W; Glueck JS; Legro RS; Carmina E; ; ;
Endocr Pract; 2015 Dec; 21(12):1415-26. PubMed ID: 26642102
[TBL] [Abstract][Full Text] [Related]
17. Insulin-like growth factor 2 mRNA-binding protein 2-regulated alternative splicing of nuclear factor 1 C-type causes excessive granulosa cell proliferation in polycystic ovary syndrome.
Zhao F; Wu L; Wang Q; Zhao X; Chen T; Yin C; Yan L; Yang X
Cell Prolif; 2022 Apr; 55(4):e13216. PubMed ID: 35293050
[TBL] [Abstract][Full Text] [Related]
18. Gestational diabetes mellitus - A metabolic and reproductive disorder.
Choudhury AA; Devi Rajeswari V
Biomed Pharmacother; 2021 Nov; 143():112183. PubMed ID: 34560536
[TBL] [Abstract][Full Text] [Related]
19. Expression of IGF-II mRNA-binding proteins (IMPs) in gonads and testicular cancer.
Hammer NA; Hansen Tv; Byskov AG; Rajpert-De Meyts E; Grøndahl ML; Bredkjaer HE; Wewer UM; Christiansen J; Nielsen FC
Reproduction; 2005 Aug; 130(2):203-12. PubMed ID: 16049158
[TBL] [Abstract][Full Text] [Related]
20. Polycystic ovary syndrome as an independent risk factor for gestational diabetes and hypertensive disorders of pregnancy: a population-based study on 9.1 million pregnancies.
Mills G; Badeghiesh A; Suarthana E; Baghlaf H; Dahan MH
Hum Reprod; 2020 Jul; 35(7):1666-1674. PubMed ID: 32535629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
